Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors

scientific article published on 27 April 2020

Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/CANCERS12051081
P932PMC publication ID7281601
P698PubMed publication ID32349217

P50authorAaron CiechanoverQ233205
Gordon B. MillsQ28086262
Matias A BustosQ94459359
P2093author name stringYing Mao
Xiaowen Wang
Kevin Tran
Dave S B Hoon
Daniel F Kelly
Romela Irene Ramos
Xiaoqing Zhang
Cong Tan
Matthew P Salomon
Shu-Ching Chang
Yuuki Iida
Yelena Kravtsova-Ivantsiv
Rebecca Gentry
P2860cites workMultivariate or multivariable regression?Q24601735
IDH1 and IDH2 mutations in gliomasQ24648948
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Q24651548
Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic TestingQ26801060
NF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageQ26830388
USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1Q28583199
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomyQ33762745
A pan-cancer proteomic perspective on The Cancer Genome Atlas.Q33944976
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phaseQ34365993
Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity.Q35711136
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.Q36557197
Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagyQ36591350
Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissueQ36695468
Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasivenessQ36982983
The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppressionQ36998038
The diverse and complex roles of NF-κB subunits in cancerQ37976939
NF-κB and the link between inflammation and cancerQ37995696
The apparent uPA/PAI-1 paradox in cancer: more than meets the eye.Q38093473
Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.Q38480250
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapyQ38624686
NFKB1: a suppressor of inflammation, ageing and cancerQ38668336
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.Q38847201
miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro.Q38925936
KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growthQ42475469
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancerQ43807549
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.Q45918451
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.Q46410671
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal disseminationQ47126029
E3 ubiquitin ligases in cancer and implications for therapiesQ47636038
The roles of ubiquitin modifying enzymes in neoplastic diseaseQ47783548
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomasQ48452453
WHO 2016 Classification of gliomas.Q50501884
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.Q53509559
Predominance of triple wild-type and IGF2R mutations in mucosal melanomasQ58093307
Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypesQ58556913
Significance of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 (PAI-1) Expression in Human Colorectal CarcinomasQ62606080
The landscape of the mesenchymal signature in brain tumoursQ64101370
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsQ77493218
KPC1 expression and essential role after acute spinal cord injury in adult ratQ83180931
The unravelling of the ubiquitin systemQ87176733
[A plasminogen regulation system in brain tumors]Q88106467
Comparison of glioblastoma (GBM) molecular classification methodsQ90384559
Glioblastoma Multiforme: An Overview of Emerging Therapeutic TargetsQ90734706
Stabilization of p27Kip1/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle controlQ90977486
Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring DiseaseQ99351983
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P921main subjectglioblastomaQ282142
P577publication date2020-04-27
P1433published inCancersQ27722963
P1476titleDownregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors
P478volume12

Search more.